Learn more

PRIMEVAX IMMUNO ONCOLOGY INC

Overview
  • Total Patents
    30
  • GoodIP Patent Rank
    53,312
  • Filing trend
    ⇧ 100.0%
About

PRIMEVAX IMMUNO ONCOLOGY INC has a total of 30 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SHANGHAI SUNWAY BIOTECH CO LTD, TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO LTD and VAXIN INC.

Patent filings per year

Chart showing PRIMEVAX IMMUNO ONCOLOGY INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lyday Bruce W 27
#2 Chen Tony 12
#3 Bruce W Lyday 2
#4 Tony Chen 1

Latest patents

Publication Filing date Title
SG11201912163WA Compositions and methods for cancer therapy with dengue virus and dendritic cells
EP3565567A1 Compositions and methods for therapy with dengue virus
EP3541417A1 Combination immunotherapies for treatment of cancer
CA2999881A1 Compositions and methods for producing dendritic cells
CN107921063A For the composition and method using dengue virus and the conjoint therapy of dendritic cells